2022
DOI: 10.33963/kp.a2021.0180
|View full text |Cite
|
Sign up to set email alerts
|

Right ventricular wall thickness indexed to body surface area as an echocardiographic predictor of acute pulmonary embolism in high-risk patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 9 publications
0
5
0
Order By: Relevance
“…In the review by Pruszczyk and Konstantinides, elevated echocardiography imaging indexes are included in risk factors that may affect initially normotensive patients with PE and move them to the group of patients with intermediate-risk [35]. Another study aimed to assess usefulness of classic echocardiographic parameters indexed to height and body surface area for prediction of acute PE in patients with a high clinical probability of PE referred for computed tomography pulmonary angiography [36]. The authors of an expert opinion screening for patients with chronic thromboembolic pulmonary hypertension after acute PE claim that TTE is a preferred screening test for chronic thromboembolic pulmonary hypertension and should be performed in any patient with dyspnea of unclear cause after a history of acute PE and at least 3 months of optimal antithrombotic therapy [37].…”
Section: Discussionmentioning
confidence: 99%
“…In the review by Pruszczyk and Konstantinides, elevated echocardiography imaging indexes are included in risk factors that may affect initially normotensive patients with PE and move them to the group of patients with intermediate-risk [35]. Another study aimed to assess usefulness of classic echocardiographic parameters indexed to height and body surface area for prediction of acute PE in patients with a high clinical probability of PE referred for computed tomography pulmonary angiography [36]. The authors of an expert opinion screening for patients with chronic thromboembolic pulmonary hypertension after acute PE claim that TTE is a preferred screening test for chronic thromboembolic pulmonary hypertension and should be performed in any patient with dyspnea of unclear cause after a history of acute PE and at least 3 months of optimal antithrombotic therapy [37].…”
Section: Discussionmentioning
confidence: 99%
“…A standard diagnostic protocol comprised determination in all patients on the day of admission to the ward the laboratory parameters including serum concentrations of troponin T, N-terminal pro B-type natriuretic peptide (NT-proBNP) and D-dimer with laboratory methods summarized formerly [14]. TTE was performed within 24 hours after admission to the ward by an experienced sonographer cardiologist (JW) using echocardiographic systems of Vivid S60N or Vivid S6 (General Electric Company, Boston, MA, US) according to the unified protocol [14][15][16]. The measurements were made based on the current guidelines of European Association of Cardiovascular Imaging with real-time electrocardiographic recording executed in order to accurately define the heart cycle phases [17].…”
Section: Methodsmentioning
confidence: 99%
“…Commercially available echocardiographic systems of Vivid S60 N or Vivid S6 (General Electric Company, Boston, Massachusetts, United States of America) were used. All TTEs were executed according to a predefined protocol [16,17].…”
Section: Methodsmentioning
confidence: 99%
“…Commercially available echocardiographic systems of Vivid S60 N or Vivid S6 (General Electric Company, Boston, Massachusetts, United States of America) were used. All TTEs were executed according to a predefined protocol [16,17]. The measurements were made based on the current guidelines of the European Association of Cardiovascular Imaging (EACVI) with real-time electrocardiographic recording in order to precisely define the phases of the heart cycle [18].…”
Section: Methodsmentioning
confidence: 99%